ESC Congress 2022 — In this short and practice-focused review, Dr Afzal Sohaib, Electrophysiologist at Barts Health NHS Trust, shares his thoughts on the top 3 trials that will impact his practice.
Trials covered in detail include:
00:18: eBRAVE-AF: eHealth-based Bavarian Alternative Detection of Atrial Fibrillation: A Randomized Controlled Trial
01:34: CAPLA: Catheter ablation for persistent atrial fibrillation: A multicenter randomized trial of pulmonary vein isolation (PVI) versus PVI with posterior left atrial wall isolation (PWI) (01:34)
02:20: INVICTUS: INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority(02:20)
For more ESC coverage browse our ESC Late-breaking Science Collection.